Showing items 1 - 20 of 20

Your selections:

A High Throughput Approach for Designing Polymers That Mimic the TRAIL Protein

TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis

3-Bromopyruvate enhances TRAIL-induced apoptosis in human nasopharyngeal carcinoma cells through CHOP-dependent upregulation of TRAIL-R2

A novel role for the TRAIL signalling pathway in the pathogenesis of Eosinophilic Oesophagitis

The role of TRAIL-regulated signalling pathways and TLR7 in rhinovirus-induced exacerbation of allergic airways disease

TRAIL signaling is proinflammatory and proviral in a murine model of rhinovirus 1B infection

Investigation of pathogenesis of chronic obstructive pulmonary disease

TRAIL deficiency and PP2A activation with salmeterol ameliorates egg allergen-driven eosinophilic esophagitis

Immune mechanisms that underpin early-life Chlamydia respiratory infection-induced chronic lung disease

Inhibition of MEK sensitizes gastric cancer cells to TRAIL-induced apoptosis

Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease

Down-regulation of RIP1 by 2-deoxy-D-glucose sensitizes breast cancer cells to TRAIL-induced apoptosis

Sensitising human melanoma cells to TRAIL-induced apoptosis

Novel therapeutic approaches for the treatment of allergic airways disease

Contrasting effects of Nutlin-3 on TRAIL- and Docetaxel-induced Apoptosis due to upregulation of TRAIL-R2 and Mcl-1 in human melanoma cells

Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIPL from degradation by the E3 ligase itch in human melanoma cells

TRAIL-induced apoptosis of human melanoma cells involves activation of caspase-4

2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2

Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor–related apoptosis-inducing ligand

TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit